2020
DOI: 10.1093/ofid/ofaa281
|View full text |Cite
|
Sign up to set email alerts
|

Beyond the Superficial: Disseminated Trichophyton rubrum Infection in a Kidney Transplant Recipient

Abstract: Abstract Superficial dermatophyte infections are common in the general population and are readily treated with topical antifungals. Deeper invasion is rare, and dissemination to visceral organs is extremely uncommon. We describe a 66 year old renal transplant recipient who developed disseminated Trichophyton rubrum infection while undergoing treatment for acute humoral rejection. The infection presented as a facial rash with subsequent dissemination to the lungs … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Dermatophytoses are characterized by superficial invasion by fungal hyphae in the skin, hair, and nails causing subacute or chronic infections (Burstein et al 2020 ). Although dermatophyte infections are restricted to areas of the epidermis, they can be invasive and cause serious widespread infections in immunocompromised patients (Trottier et al 2020 ). Major risk factors for the development of invasive fungal infections include, among others, HIV treatment in AIDS patients, cytotoxic chemotherapy in cancer patients, immunosuppressive therapy where innate defenses have been breached and the presence of catheters and other indwelling devices (Casadevall 2019 ; Li et al 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Dermatophytoses are characterized by superficial invasion by fungal hyphae in the skin, hair, and nails causing subacute or chronic infections (Burstein et al 2020 ). Although dermatophyte infections are restricted to areas of the epidermis, they can be invasive and cause serious widespread infections in immunocompromised patients (Trottier et al 2020 ). Major risk factors for the development of invasive fungal infections include, among others, HIV treatment in AIDS patients, cytotoxic chemotherapy in cancer patients, immunosuppressive therapy where innate defenses have been breached and the presence of catheters and other indwelling devices (Casadevall 2019 ; Li et al 2020 ).…”
Section: Introductionmentioning
confidence: 99%